A myopathy with unusual features caused by PNPLA2 gene mutations

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Muscle and Nerve

• Publication date

  2015-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/mus.24477PMID 25287355
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Symptomatic lipid storage in carriers for the PNPLA2 gene

  2012cited by this paper
• Contribution of novel ATGL missense mutations to the clinical phenotype of NLSD-M: a strikingly low amount of lipase activity may preserve cardiac function.

  2012cited by this paper
• A novel mutation in PNPLA2 leading to neutral lipid storage disease with myopathy.

  2012cited by this paper
• Blocked muscle fat oxidation during exercise in neutral lipid storage disease.

  2012cited by this paper
• FAT SIGNALS - Lipases and Lipolysis in Lipid Metabolism and Signaling

  2012cited by this paper
• Investigation and Functional Characterization of Rare Genetic Variants in the Adipose Triglyceride Lipase in a Large Healthy Working Population

  2010influential reference
• Clinical and genetic characterization of chanarin-dorfman syndrome patients: first report of large deletions in the ABHD5 gene

  2010cited by this paper
• Neutral lipid storage disease with subclinical myopathy due to a retrotransposal insertion in the PNPLA2 gene.

  2010cited by this paper
• Neutral lipid storage disease: genetic disorders caused by mutations in adipose triglyceride lipase/PNPLA2 or CGI-58/ABHD5.

  2009cited by this paper
• The gene encoding adipose triglyceride lipase (PNPLA2) is mutated in neutral lipid storage disease with myopathy

  2007influential reference
• Improved cytochemical method for detecting Jordans’ bodies in neutral lipid storage diseases

  2006cited by this paper
• Mutations in CGI-58, the gene encoding a new protein of the esterase/lipase/thioesterase subfamily, in Chanarin-Dorfman syndrome.

  2001cited by this paper
• Successful treatment of familial idiopathic lipid storage myopathy with L‐carnitine and modified lipid diet

  1982influential reference
• Multisystem triglyceride storage disorder with impaired long‐chain fatty acid oxidation

  1980cited by this paper

• Diagnosis of Inherited Metabolic Disease in Older Patients: A Systematic Literature Review

  2025cites this paper
• Pathophysiology and Management of Fatigue in Neuromuscular Diseases

  2023cites this paper
• Hereditary myopathies associated with hematological abnormalities

  2022cites this paper
• Analysis of mRNA and lncRNA Expression Profiles of Breast Muscle during Pigeon (Columba livia) Development

  2022cites this paper
• Case Report: PNPLA2 Gene Complex Heterozygous Mutation Leading to Neutral Lipid Storage Disease With Myopathy

  2021cites this paper
• ETF dehydrogenase advances in molecular genetics and impact on treatment

  2021cites this paper
• FOXC2 Disease Mutations Identified in Lymphedema Distichiasis Patients Impair Transcriptional Activity and Cell Proliferation

  2020cites this paper
• The Role of Metabolic Lipases in the Pathogenesis and Management of Liver Disease

  2020cites this paper
• Triglyceride deposit cardiomyovasculopathy: a rare cardiovascular disorder

  2019cites this paper
• Collection of the Abstracts of the 2019Sp PMD: Translational Myology and Mobility Medicine

  2019cites this paper
• Metabolic lipid muscle disorders: biomarkers and treatment

  2019cites this paper
• A novel PNPLA2 mutation causing total loss of RNA and protein expression in two NLSDM siblings with early onset but slowly progressive severe myopathy

  2019cites this paper
• Of mice and men: The physiological role of adipose triglyceride lipase (ATGL)☆

  2019cites this paper
• Neutral Lipid Storage Diseases as Cellular Model to Study Lipid Droplet Function

  2019cites this paper
• Patients with neutral lipid storage disease with myopathy (NLSDM) in Southwestern China.

  2018cites this paper
• Lipid storage myopathies: Current treatments and future directions.

  2018cites this paper
• Lipid Myopathies

  2018cites this paper
• Late onset of neutral lipid storage disease due to novel PNPLA2 mutations totally abrogating lipase activity in a patient with myopathy and slight cardiac involvement

  2017cites this paper
• Adipose Triglyceride Lipase Regulation: An Overview.

  2017cites this paper
• The skeletal and heart muscle triacylglycerol lipolysis revisited.

  2017cites this paper
• Late onset of neutral lipid storage disease due to novel PNPLA2 mutations causing total loss of lipase activity in a patient with myopathy and slight cardiac involvement

  2017cites this paper
• Generation of induced Pluripotent Stem Cells as disease modelling of NLSDM

  2017cites this paper
• Neutral Lipid Storage Diseases: clinical/genetic features and natural history in a large cohort of Italian patients

  2017cites this paper
• Muscle MRI in neutral lipid storage disease (NLSD)

  2017cites this paper
• MRI in neutral lipid storage disease (NLSD)

  2017cites this paper
• Neutral lipid‐storage disease with myopathy and extended phenotype with novel PNPLA2 mutation

  2016cites this paper
• Novel missense mutations in PNPLA2 causing late onset and clinical heterogeneity of neutral lipid storage disease with myopathy in three siblings.

  2015cites this paper
• [Acute rhabdomyolysis in a female heterozygotic carrier of an undescribed mutation in the PNPLA2 gene].

  2015cites this paper